2.52 USD
↘ 0.05 (1.95%)AT CLOSE (11:59 AM EDT)
Fortress Biotech, Inc. (FBIO) trades at $2.52 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (63.0%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest FBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Sep 11, 2026.